Case | Conditions | Platelets (cells/mm3) | Glucose (mg/dL) | INR | aPTT (ratio) | Creatinine (mg/dL) | ARU tests | PRU tests | Aspirin/prasugrel maintenance dose (mg/day) |
1 | T, Stroke | 247 000 | 87 | 0.95 | 1.06 | 0.51 | 403 | – | 100/– |
2 | T | 270 000 | 98 | 1.19 | 1.16 | 0.62 | 408 | – | 100/– |
3 | HBP, ADPKD | 294 000 | 88 | 0.95 | 1.07 | 1.1 | 411/455 | 77 | 100/5 |
4 | HBP, T, CF | 219 000 | 98 | 1.01 | 1.01 | 1.15 | 422 | – | 100/– |
5 | HBP | 374 000 | 91 | 0.93 | 1.03 | 0.64 | 396/464 | 22 | 100/10 |
6 | HBP, T | 180 000 | 85 | 0.98 | 1.21 | 0.64 | 411 | – | – |
7 | HBP, T, SAH | 282 000 | 93 | 1.03 | 1.3 | 0.7 | 584/379* | 32 | 300/5 |
*This patient received a load of 500 mg aspirin and was retested after 2 hours; the new ARU test was 379 units.
ADPKD, autosomic dominant polycystic kidney disease; aPTT, activated partial thromboplastin time; ARU tests, aspirin reaction units test; CF, cardiac failure; HBP, high blood pressure; PRU tests, p2y12 reaction units test; SAH, previous subarachnoid hemorrhage; T, tobacco smoking.